Fig. 3From: 3D absorbed dose distribution estimated by Monte Carlo simulation in radionuclide therapy with a monoclonal antibody targeting synovial sarcomaVariation of %peak-activity/kg with time for several lesions compared to the liver. Patients with a “T” indicated that they had been treatedBack to article page